Abstract
Original language | English |
---|---|
Pages (from-to) | 1712-1726 |
Number of pages | 15 |
Journal | European journal of neurology |
Volume | 30 |
Issue number | 6 |
Early online date | 2023 |
DOIs | |
Publication status | Published - Jun 2023 |
Keywords
- COVID-19 infection
- COVID-19 vaccination
- autonomic nervous system
- orthostatic hypotension
- postural orthostatic tachycardia syndrome
- syncope
- telemedicine
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: European journal of neurology, Vol. 30, No. 6, 06.2023, p. 1712-1726.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Impact of the COVID-19 pandemic on clinical autonomic practice in Europe
T2 - a survey of the European Academy of Neurology and the European Federation of Autonomic Societies
AU - Fanciulli, Alessandra
AU - Leys, Fabian
AU - Krbot Skorić, Magdalena
AU - Reis Carneiro, Diogo
AU - Calandra-Buonaura, Giovanna
AU - Camaradou, Jennifer
AU - Chiaro, Giacomo
AU - Cortelli, Pietro
AU - Falup-Pecurariu, Cristian
AU - Granata, Roberta
AU - Guaraldi, Pietro
AU - Helbok, Raimund
AU - Hilz, Max J.
AU - Iodice, Valeria
AU - Jordan, Jens
AU - Kaal, Evert C. A.
AU - Kamondi, Anita
AU - Pavy le Traon, Anne
AU - Rocha, Isabel
AU - Sellner, Johann
AU - Senard, Jean Michel
AU - Terkelsen, Astrid
AU - Wenning, Gregor K.
AU - Moro, Elena
AU - Berger, Thomas
AU - Thijs, Roland D.
AU - Struhal, Walter
AU - Habek, Mario
AU - the Collaborators of European Network of Neurological ANS laboratories
AU - Adamec, Ivan
AU - Aerts, Arnaud
AU - Campese, Nicole
AU - Canta, Leo L. R.
AU - Delamont, Robert Shane
AU - de Lange, Frederik
AU - del Sorbo, Francesca
AU - Devigili, Grazia
AU - di Leo, Rita
AU - Dinh, Trang
AU - Fortrat, Jacques-Olivier
AU - Gierthmühlen, Janne
AU - Hemels, Martin
AU - Köhn, Julia
AU - Krøigård, Thomas
AU - Lipp, Axel
AU - Maier, Andrea
AU - Marinelli, Lucio
AU - Mazzeo, Anna
AU - Milenkovic, Ivan
AU - Motyl, Maciej
AU - Sora, Maria Grazia Natali
N1 - Funding Information: The authors would like to thank Ms Lucia Pavlakova and Ms Abigail Magno (Scientific Department, European Academy of Neurology) for the excellent administrative support and the following collaborators of the European Network of Neurological ANS laboratories for their thoughtful completion of the survey: Ivan Adamec—Department of Neurology, University Hospital Centre Zagreb, Zagreb, Croatia; Arnaud Aerts—Department of Cardiology, Zuyderland Medical Centre, Heerlen, Netherlands; Nicole Campese—Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria; Leo LR Canta—Department of Neurology, Catharina Ziekenhuis, Eindhoven, Netherlands; Robert Shane Delamont—Department of Neurology and Clinical Neurophysiology, King's College Hospital, London, UK; Frederik de Lange—Syncope Unit, Amsterdam University Medical Center, Amsterdam, Netherlands; Francesca Del Sorbo—Parkinson and Movement Disorders Unit, ASST Gaetano Pini-CTO, Milano, Italy; Grazia Devigili—Parkinson and Movement Disorder Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy; Rita Di Leo—Department of Neurology, Ospedale San Giovanni e Paolo, Venezia, Italy; Trang Dinh—Department of Cardiology, Maastricht University Medical Center, Maastricht, Netherlands; Jacques-Olivier Fortrat—Explorations Fonctionnelles Vasculaires, Centre Hospitalier Universitaire, Angers, France; Janne Gierthmühlen—Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany; Martin Hemels—Department of Cardiology, Rijnstate Hospital and Radboud University Medical Center, Arnhem–Nijmegen, Netherlands; Julia Köhn—Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany; Thomas Krøigård—Department of Neurology, Odense University Hospital, Odense, Denmark; Axel Lipp—Department of Neurology, Park-Klinik Weißensee, Berlin, Germany; Andrea Maier—Department of Neurology, Outpatient Service for ANS Disorders, University Clinic RWTH Aachen, Aachen, Germany; Lucio Marinelli—Department of Neuroscience, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Anna Mazzeo—Department of Clinical and Experimental Medicine, Neurology and Neuromuscular Disease Unit, Messina, Italy; Ivan Milenkovic—Department of Neurology, Medical University of Vienna, Vienna, Austria; Maciej Motyl—Department of Neurology, Jagiellonian University Medical College, Krakow, Poland; Maria Grazia Natali Sora—Department of Neurology, Ospedale San Raffaele, Milano, Italy; Judith Navarro-Otano—Department of Neurology, Hospital Clinic, Barcelona, Spain; Kristian Bernhard Nilsen—Department of Neurology, Oslo University Hospital, Oslo University Hospital, Norway; Mario Oliveira—Department of Cardiology, Santa Marta Hospital, Lisbon, Portugal; Petter Moe Omland—Department of Neurology, Section of Clinical Neurophysiology, St Olavs University Hospital, Trondheim, Norway; Giuseppe Pelliccioni—Department of Neurology, Istituto Nazionale di Ricovero e Cura per Anziani IRCCS Ancona, Ancona, Italy; Yann Pereon—Reference Centre from Neuromuscular Disorders, Department of Neurology, University Hospital, Nantes, France; Roland Josef Resch—Department of Neurology, Kepler University, Linz, Austria; Camilla Rocchi—Department of Neurology, Policlinico Tor Vergata, University of Rome “Tor Vergata”, Rome, Italy; Frederic Roche—Department of Clinical Physiology, CHU And INSERM U 1059 Sainbiose, Saint Étienne, France; Joost Rutten–Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands; Beatriz Tijero-Merino—Movement Disorders and Autonomic Disorders Unit, Cruces Hospital, Barakaldo, Spain; Marcin Tutaj—Department of Neurology, Jagiellonian University Medical College, Krakow, Poland; A. M. H. G. van der Heijden-Montfroy—Department of Neurology, VieCuri, Venlo, Netherlands; Bas J. A. van Hoeve—Department of Neurology, ZorgSaam Hospital, Terneuzen, Netherlands; Narender van Orshoven—Department of Neurology, Zuyderland Medical Centre, Heerlen, Netherlands; Ruihao Wang—Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany; Werner J Z'Graggen—Department of Neurology, University Hospital Bern, Bern, Switzerland. Funding Information: Academic study without targeted external financial support. Administrative support was received from the EAN Head Office. Dr Fanciulli and Dr Leys received travel grants by the Austrian Exchange Program (Österreichischer Austausch Dienst). Dr Leys is supported by the US MSA Coalition and the Johannes und Hertha Tuba Foundation. Publisher Copyright: © 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
PY - 2023/6
Y1 - 2023/6
N2 - Background and purpose: The objective was to investigate the impact of the coronavirus disease 2019 (COVID-19) pandemic on European clinical autonomic practice. Methods: Eighty-four neurology-driven or interdisciplinary autonomic centers in 22 European countries were invited to fill in a web-based survey between September and November 2021. Results: Forty-six centers completed the survey (55%). During the first pandemic year, the number of performed tilt-table tests, autonomic outpatient and inpatient visits decreased respectively by 50%, 45% and 53%, and every third center reported major adverse events due to postponed examinations or visits. The most frequent newly diagnosed or worsened cardiovascular autonomic disorders after COVID-19 infection included postural orthostatic tachycardia syndrome, orthostatic hypotension and recurrent vasovagal syncope, deemed to be likely related to the infection by ≥50% of the responders. Forty-seven percent of the responders also reported about people with new onset of orthostatic intolerance but negative tilt-table findings, and 16% about people with psychogenic pseudosyncope after COVID-19. Most patients were treated non-pharmacologically and symptomatic recovery at follow-up was observed in ≥45% of cases. By contrast, low frequencies of newly diagnosed cardiovascular autonomic disorders following COVID-19 vaccination were reported, most frequently postural orthostatic tachycardia syndrome and recurrent vasovagal syncope, and most of the responders judged a causal association unlikely. Non-pharmacological measures were the preferred treatment choice, with 50%–100% recovery rates at follow-up. Conclusions: Cardiovascular autonomic disorders may develop or worsen following a COVID-19 infection, whilst the association with COVID-19 vaccines remains controversial. Despite the severe pandemic impact on European clinical autonomic practice, a specialized diagnostic work-up was pivotal to identify non-autonomic disorders in people with post-COVID-19 orthostatic complaints.
AB - Background and purpose: The objective was to investigate the impact of the coronavirus disease 2019 (COVID-19) pandemic on European clinical autonomic practice. Methods: Eighty-four neurology-driven or interdisciplinary autonomic centers in 22 European countries were invited to fill in a web-based survey between September and November 2021. Results: Forty-six centers completed the survey (55%). During the first pandemic year, the number of performed tilt-table tests, autonomic outpatient and inpatient visits decreased respectively by 50%, 45% and 53%, and every third center reported major adverse events due to postponed examinations or visits. The most frequent newly diagnosed or worsened cardiovascular autonomic disorders after COVID-19 infection included postural orthostatic tachycardia syndrome, orthostatic hypotension and recurrent vasovagal syncope, deemed to be likely related to the infection by ≥50% of the responders. Forty-seven percent of the responders also reported about people with new onset of orthostatic intolerance but negative tilt-table findings, and 16% about people with psychogenic pseudosyncope after COVID-19. Most patients were treated non-pharmacologically and symptomatic recovery at follow-up was observed in ≥45% of cases. By contrast, low frequencies of newly diagnosed cardiovascular autonomic disorders following COVID-19 vaccination were reported, most frequently postural orthostatic tachycardia syndrome and recurrent vasovagal syncope, and most of the responders judged a causal association unlikely. Non-pharmacological measures were the preferred treatment choice, with 50%–100% recovery rates at follow-up. Conclusions: Cardiovascular autonomic disorders may develop or worsen following a COVID-19 infection, whilst the association with COVID-19 vaccines remains controversial. Despite the severe pandemic impact on European clinical autonomic practice, a specialized diagnostic work-up was pivotal to identify non-autonomic disorders in people with post-COVID-19 orthostatic complaints.
KW - COVID-19 infection
KW - COVID-19 vaccination
KW - autonomic nervous system
KW - orthostatic hypotension
KW - postural orthostatic tachycardia syndrome
KW - syncope
KW - telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85151683023&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/ene.15787
DO - https://doi.org/10.1111/ene.15787
M3 - Article
C2 - 36920252
SN - 1351-5101
VL - 30
SP - 1712
EP - 1726
JO - European journal of neurology
JF - European journal of neurology
IS - 6
ER -